Sign up to save your podcasts
Or
Share Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow
Are you selecting the right Bruton tyrosine kinase (BTK) inhibitor for your patients with chronic lymphocytic leukemia (CLL)? Experts discuss the key differentiators and upcoming developments in the field. Credit available for this activity expires: 04/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000717?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
Are you selecting the right Bruton tyrosine kinase (BTK) inhibitor for your patients with chronic lymphocytic leukemia (CLL)? Experts discuss the key differentiators and upcoming developments in the field. Credit available for this activity expires: 04/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000717?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
JAMA Editors' Summary
129 Listeners
The Bob Harrington Show
13 Listeners
NEJM This Week
313 Listeners
This Week in Cardiology
853 Listeners
JAMA Clinical Reviews
488 Listeners
AFP: American Family Physician Podcast
695 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
264 Listeners
Frankly Speaking About Family Medicine
255 Listeners
The Curbsiders Internal Medicine Podcast
3,317 Listeners
Emergency Medical Minute
250 Listeners
JAMA Medical News
89 Listeners
Core IM | Internal Medicine Podcast
1,069 Listeners
Annals On Call Podcast
169 Listeners
The Clinical Problem Solvers
506 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
317 Listeners
Medicine and the Machine
58 Listeners
Keeping Current CME
24 Listeners
Ninja Nerd
268 Listeners